))
Ep. 71 - Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments
Manage episode 447887439 series 3571902
Sisällön tarjoaa BioCentury. BioCentury tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Richard Pazdur, director of FDA’s Oncology Center of Excellence, joined FDA in 1999. Looking back on his 25th anniversary, he draws a line between unpopular decisions at the start of his tenure and a surge in cancer drug development over the last 20 years. He believes this and other lessons from the regulation of oncology can be applied broadly across FDA. The BioCentury Show discussed these lessons, as well as Pazdur’s views about advisory committees, pragmatic trials, dose optimization and more.
This episode of The BioCentury Show was sponsored by Cytiva. To gain more insights into therapeutic advances and biopharma sustainability, read the report now available on cytiva.com.
View full story: https://www.biocentury.com/article/654032
#biotech #biopharma #pharma #lifescience #RandD #drugapproval #regulation
00:00 - Introduction
01:55 - Rejecting the ineffective
10:56 - Creating Consensus
16:43 - Fire From the Dragon’s Mouth
24:30 - Three Reasons for Trial Equity
29:28 - Dose Optimization
Luvut
1. Ep. 71 - Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments (00:00:00)
2. Rejecting the ineffective (00:01:55)
3. Creating Consensus (00:10:56)
4. Fire From the Dragon’s Mouth (00:16:43)
5. Three Reasons for Trial Equity (00:24:30)
6. Dose Optimization (00:29:28)
21 jaksoa
Jaa
